There is a newer version of the record available.

Published May 20, 2026 | Version v1
Presentation Restricted

EMVA Skin: An Autonomous Multispectral Screening and Triage System Utilizing High-Resolution Diffuse Reflectance Spectroscopy and Artificial Intelligence

Description

The EMVA Skin Project introduces a novel system architecture for public preventive health screening through an autonomous, non-invasive kiosk terminal designed for pharmacies and primary care facilities. The system bridges the gap between industrial-grade optical metrology and predictive healthcare triage.

Key Technical and Clinical Features:

Hardware Integration: The terminal integrates an industrial-grade spectrophotometer into an ergonomic user-facing kiosk, utilizing a precise LED light source to capture diffuse reflectance spectra across the 380 - 730 nm range directly from the user's forearm.

Multisystem Triage Capabilities: Rather than focusing on a single pathology, the EMVA cloud-based AI algorithm analyzes the complex optical signatures of dermal tissue to identify early structural, chemical, and vascular biomarkers:

Oncology: Mapping early cell texture anomalies, melanin plate alterations, and systemic angiogenic acceleration signals (530 - 580 nm}).

Cardiovascular & Circulatory: Detecting peripheral tissue hypoxia and blood oxygenation anomalies via the flattening of the oxyhemoglobin spectral curve 540 - 580 nm).

Metabolic & Hepatic: Monitoring advanced glycation end-products (AGEs) (420 - 440 nm) as a pre-diabetes indicator, and tissue bilirubin accumulation (450 - 480nm) to detect early hepatobiliary stress.

Operational Stability: Long-term clinical calibration drift is mitigated through autonomous daily reference tile alignments and periodic digital recertification technology, bypassing the need for factory recalls.

Conclusion & Objective:

The EMVA Terminal does not serve as a definitive diagnostic tool, but as a high-throughput, non-invasive digital sieve. By generating instant, multi-system health vitality reports during routine pharmacy visits, it flags subclinical anomalies and routes asymptomatic patients to specialist medical practitioners, maximizing the window for 100% successful preventive intervention

Files

Restricted

The record is publicly accessible, but files are restricted. Log in to check if you have access.